« Open-Source Pharmaceutical Babble |
Main
| Let's Just Spread This Deal Out All Over the Paper, Why Don't We? »
July 29, 2010
New from OSI / Astellas
Posted by Derek
When last we heard about the takeover of OSI by Astellas, everyone was standing around wondering what was going to happen. Some of that uncertainly seems, unfortunately, to be vanishing. A source tells me that the OSI people have been informed that their Ardsley headquarters and the Melville site on Long Island are to close. The fate of the Farmingdale site on LI is still unclear. Ardsley used to be where Purdue Pharma had a lot of people, and I don't think that OSI has been there that long, actually.
I've also heard that development staff at OSI have been told that they're being let go, but are free to re-apply to Astellas - that could mean several things, none of them particularly good, but that's all I have so far.
Comments (5)
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- › Academia and Industry, Suing Each Other
- › Let's Start Off the Meeting With An Ad, OK?
- › The Academic-Industrial Collaboration in Drug Discovery Panel: Today
- › Glass Structure, Atom by Atom
- › How the Andrulis Paper Got Published
- › AstraZeneca in Waltham
- › Fluorine NMR: Why Not?
- › AstraZeneca Layoffs and Closings
1. Hap on July 29, 2010 11:35 AM writes...
Wow. The "you can reapply for your old job" bit is always endearing, like Satan Jr. practicing his moves before he moves up to the top spot. I hope there's a warm spot somewhere for the HR people who came up with that idea.
Why don't they ever do that with board members or CEOs?
Permalink to Comment2. petros on July 29, 2010 1:47 PM writes...
What about the UK site (OSI (prosidion))?
Permalink to Comment3. Ed on July 29, 2010 2:27 PM writes...
"WE'RE DOOMED!"
Permalink to Comment4. Chemaniac on August 2, 2010 7:16 AM writes...
Well, it's official now. From the FiercePharma site:
http://www.fiercepharma.com/story/astellas-shutter-n-y-facilities-cut-jobs/2010-07-30
Permalink to Comment5. Anonymous on August 4, 2010 8:59 PM writes...
I'm surprised Roche didn't step in an kick Astellas to the curb. Hey, OSI has tarceva and others including a glucokinase activator that appears to be progressing. Remember where glucokinase activators originated??
Permalink to Comment